K. Selmaj et al., Naked DNA vaccination differentially modulates autoimmune responses in experimental autoimmune encephalomyelitis, J NEUROIMM, 111(1-2), 2000, pp. 34-44
Vaccination with naked DNA represents a therapeutic strategy currently unde
r consideration in multiple sclerosis (MS). In this study, we tested the po
tential therapeutic effect of vaccination with a naked DNA construct encodi
ng proteolipid protein (pRc/CMV-PLP) upon the outcome of subsequent sensiti
zation for experimental autoimmune encephalomyelitis (EAE) actively-induced
in Sn mice with PLP139-151 peptide in adjuvant. Intramuscular vaccination
with the naked DNA pRc/CMV-PLP construct led to PLP expression in local mus
cle tissue that persisted for about 8 weeks. Early sensitization for EAE (4
weeks after DNA vaccination) caused recipient mice to develop a severe, ex
acerbated form of disease tin comparison to control mice), while late sensi
tization (>10 weeks) resulted in a milder, ameliorated form. In the groups
sensitized <10 weeks post-DNA vaccination with pRc/CMV-PLP induction of a T
h1-type cytokine response was noted. In contrast, sensitization >10 weeks p
ost-DNA vaccination led to peripheral tolerance as evidenced by a decrease
in T cell proliferation and cytotoxic T cell response, no Th2 response, and
no increase in apoptosis. These data are novel in that they demonstrate a
differential effect of DNA vaccination and have important implications for
its use as a mechanism to enhance or modulate immune reactivity. (C) 2000 P
ublished by Elsevier Science B.V.